These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 24848253)

  • 1. A stiffness-mediated oncogenic hammer.
    Ghajar CM
    Sci Transl Med; 2014 May; 6(237):237fs21. PubMed ID: 24848253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rab40b and Tks5 interact at invadopodia during metastasis.
    J Cell Sci; 2016 Dec; 129(23):e2301. PubMed ID: 27909076
    [No Abstract]   [Full Text] [Related]  

  • 3. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
    Patel JB; Appaiah HN; Burnett RM; Bhat-Nakshatri P; Wang G; Mehta R; Badve S; Thomson MJ; Hammond S; Steeg P; Liu Y; Nakshatri H
    Oncogene; 2011 Mar; 30(11):1290-301. PubMed ID: 21057539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular matrix components in breast cancer progression and metastasis.
    Oskarsson T
    Breast; 2013 Aug; 22 Suppl 2():S66-72. PubMed ID: 24074795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs and breast cancer malignancy: an overview of miRNA-regulated cancer processes leading to metastasis.
    Harquail J; Benzina S; Robichaud GA
    Cancer Biomark; 2012; 11(6):269-80. PubMed ID: 23248185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-mediated breast cancer metastasis: from primary site to distant organs.
    Wang L; Wang J
    Oncogene; 2012 May; 31(20):2499-511. PubMed ID: 21963843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF; Yan PJ; Shao ZM
    Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix.
    Eckhardt BL; Parker BS; van Laar RK; Restall CM; Natoli AL; Tavaria MD; Stanley KL; Sloan EK; Moseley JM; Anderson RL
    Mol Cancer Res; 2005 Jan; 3(1):1-13. PubMed ID: 15671244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ECM stiffness paves the way for tumor cells.
    Seewaldt V
    Nat Med; 2014 Apr; 20(4):332-3. PubMed ID: 24710372
    [No Abstract]   [Full Text] [Related]  

  • 10. MicroRNAs in breast cancer pathogenesis.
    Götte M
    Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differential expression profiles of microRNAs between breast cancer cells and mammary epithelial cells].
    Zhang H; Su SB; Zhou QM; Lu YY
    Ai Zheng; 2009 May; 28(5):493-9. PubMed ID: 19624877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis.
    Shi M; Liu D; Duan H; Shen B; Guo N
    Cancer Metastasis Rev; 2010 Dec; 29(4):785-99. PubMed ID: 20938719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling.
    Ma F; Zhang J; Zhong L; Wang L; Liu Y; Wang Y; Peng L; Guo B
    Gene; 2014 Feb; 535(2):191-7. PubMed ID: 24315818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer.
    Nagpal N; Ahmad HM; Molparia B; Kulshreshtha R
    Carcinogenesis; 2013 Aug; 34(8):1889-99. PubMed ID: 23542418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
    Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
    Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling.
    Du WW; Fang L; Li M; Yang X; Liang Y; Peng C; Qian W; O'Malley YQ; Askeland RW; Sugg SL; Qian J; Lin J; Jiang Z; Yee AJ; Sefton M; Deng Z; Shan SW; Wang CH; Yang BB
    J Cell Sci; 2013 Mar; 126(Pt 6):1440-53. PubMed ID: 23418360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.
    Kong LM; Liao CG; Zhang Y; Xu J; Li Y; Huang W; Zhang Y; Bian H; Chen ZN
    Cancer Res; 2014 Jul; 74(14):3764-78. PubMed ID: 24906624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oncogenic role of miR-155 in breast cancer.
    Mattiske S; Suetani RJ; Neilsen PM; Callen DF
    Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1236-43. PubMed ID: 22736789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERBB2 overexpression triggers transient high mechanoactivity of breast tumor cells.
    Martin M; Müller K; Cadenas C; Hermes M; Zink M; Hengstler JG; Käs JA
    Cytoskeleton (Hoboken); 2012 May; 69(5):267-77. PubMed ID: 22407943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.
    Shi M; Guo N
    Cancer Treat Rev; 2009 Jun; 35(4):328-34. PubMed ID: 19171434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.